Chinese medicine capsule for treating hyperplasia of mammary glands and its producing method

Abstract

The present invention relates to Chinese medicine capsule for treating hyperplasia of mammary glands and its preparation process. The Chinese medicine capsule is prepared with the Chinese medicinal materials including nutagrass flatsedge rhizome, red sage, bupleurum root, white peony root, trichosanthes fruit and sweetgum fruit. The preparation process includes mixing and decocting nutagrass flatsedge rhizome, bupleurum root, white peony root, trichosanthes fruit and sweetgum fruit, concentrating while collecting volatile oil, clathrating with beta-cyclodextrin, alcohol extracting and water extracting red sage, merging the extractum and drying, and capsulizing. The present invention has simple and scientific recipe, rich material, low cost, good clinical effect and other advantages.

Description

1. Technical field [0001] The invention relates to a traditional Chinese medicine capsule for treating mammary gland hyperplasia for treating gynecological breast diseases and a production method thereof. 2. Background technology [0002] Mammary gland hyperplasia is a common and frequently-occurring disease in gynecology. The incidence rate is extremely high in women aged 20-50. Its symptoms are multiple round and tough nodules of different sizes in one or both breasts, often accompanied by breast distending pain, especially before menstruation. Current research shows that the cancerous rate of mammary gland hyperplasia is about 20%, so the research on this disease has attracted much attention in recent years. When the country formulated the "Tenth Five-Year Plan", the research on medication for common (gynecological) diseases has been listed as a key funding scope. Western medicine mostly adopts hormone therapy (proterosterone or methyltestosterone etc.) to the treatment...

AI Technical Summary

Problems solved by technology

At present, the treatment of traditional Chinese medicine for this disease is mainly based on clinical decoction, which limits its popularization and application.

Although there are Chinese patent medicines such as Rupixiao Tablets, Rukuaixiao Tablets, and Rukang Tablets, most of them are local standard drugs that were approved by the provinces before the implementation of the New Drug Application Approval Measures. Either because of the cost or because of its curative effect, or because of its quality or because of the wrong medicine, it is far from meeting the clinical needs, and the clinical curative effect needs to be further improved.